Cytokinetics may be counting down the days until the FDA decides whether to approve its cardiovascular drug aficamten. | ...

Medtronic posted a slate of strong quarterly financial results this morning, with its cardiovascular device portfolio pushing ...

The investment bank Jefferies had been running its healthcare conference in London for 14 years as a reasonably intimate ...

Roche has reported another phase 3 win for its oral selective estrogen receptor degrader (SERD). Success at a planned interim ...

Cornerstone Robotics secured about $200 million in its second round of financing this year, which the Hong Kong-based company ...

Vanda Pharmaceuticals’ expansion into the booming GLP-1 market has cleared a midphase test. | Vanda Pharmaceuticals’ ...

On its face, Biogen’s May 2024 acquisition of Human Immunology Biosciences (HI-Bio) | On its face, there wasn’t much notable ...

Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while ...

Genmab has shed another antibody-drug conjugate from its April 2024 acquisition of ProfoundBio. | Genmab has shed another ...

Through a collaboration with Edwards Lifesciences, Philips is rolling out new artificial intelligence tools designed to ...

The second Trump administration has been defined by widespread cuts to federal spending, including at the National Institutes ...

The startup incubator MedTech Innovator only launched in 2013, but it has had an immense impact on the industry. | Three MedTech Innovator startups showed off their diagnostic tech at the American ...